| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/04/2010 | US7709208 identification of enhanced levels of amyloid beta protein, for example A beta 40 or A beta 42 |
| 05/04/2010 | US7709207 Method for identifying compounds for treatment of pain |
| 05/04/2010 | US7709205 Antiproliferative agents; antiapoptosis; drug screening; blot analysis; immunohistochemistry; RNA interference; fluorescence in situ hybridization; determining prognosis in a subject with breast cancer, comprising determining overexpression of 14-3-3 zeta mRNA |
| 05/04/2010 | US7709202 Molecular characteristics of non-small cell lung cancer |
| 05/04/2010 | US7709199 Chronic lymphocytic leukaemia |
| 05/04/2010 | US7709196 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/04/2010 | US7709193 Detecting preferential polypeptides in sample; obtain biological sample, incubate with reducing agent and detergent, detect and extract protein from solution; useful in assessing damage to cells such as cardiac and skeletal muscle cells and in the early clinical diagnosis of myocardial damage |
| 05/04/2010 | US7709192 Binding ligand to nucleic acids; detection |
| 05/04/2010 | US7709191 for measuring the therapeutic efficacy of various HIV treatment regimes such as highly active antiretroviral therapy (HAART); Using CCR5 and CXCR4 coreceptor usage as diagnostic indicator of AIDS disease progression in patients; determining most effective antiviral treatments for AIDS patients |
| 05/04/2010 | US7709189 Methods for identifying or diagnosing carcinoma cells with metastatic potential based on the measurement of lymphoid genes or their products in carcinoma cells |
| 05/04/2010 | US7709047 Target activated microtransfer |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7709006 Hepatitis-C virus testing |
| 05/04/2010 | US7709004 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709003 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7708999 Inhibiting activity of fibroblast growth factor 8; preventing joint destruction, protecting cartilage, inhibiting growth of synovial membrane; diagnostic agent; antibody active ingredient |
| 05/04/2010 | US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 05/04/2010 | US7708997 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains |
| 05/04/2010 | US7708992 Methods for producing antibody compositions with increased ADCC |
| 05/04/2010 | US7708977 Method for diagnosis and treatment of vascular disease |
| 05/04/2010 | US7708948 Test system for analyzing body fluids |
| 05/04/2010 | US7708945 Device and method for determining multiple analytes |
| 05/04/2010 | US7708881 Magnetic bead-based sample separating device |
| 05/04/2010 | US7708701 Method and apparatus for a multi-use body fluid sampling device |
| 05/04/2010 | US7707869 FET-based gas sensor |
| 05/04/2010 | CA2643126C Reaction vessel |
| 05/04/2010 | CA2634654C Reagent compositions for analytical testing |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2443077C A "one-device" system for testing constituents in fluids |
| 05/04/2010 | CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 05/04/2010 | CA2412749C Saliva testing and confirmation device |
| 05/04/2010 | CA2398362C Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions |
| 05/04/2010 | CA2299624C Mammalian cytokine receptor - 11 |
| 05/04/2010 | CA2282439C Formulations for hydrophobic pharmaceutical agents |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA1341604C Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides |
| 04/30/2010 | CA2684158A1 Analytical test strip with minimal fill-error sample viewing window |
| 04/30/2010 | CA2683211A1 Measuring arrangement for spectroscopic examination and throughput acquisition of a crop flow |
| 04/29/2010 | WO2010048627A2 Potentiometric sensors based on surface molecular imprinting, and nanoparticle composition for the detection of cancer biomarkers and viruses and methods of use thereof |
| 04/29/2010 | WO2010048616A2 Method for screening for compounds selectively interacting with rad9 |
| 04/29/2010 | WO2010048615A2 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | WO2010048503A1 Live/dead viral load assay |
| 04/29/2010 | WO2010048424A1 Methods, compositions, and kits for diagnosing, monitoring, and treating disease |
| 04/29/2010 | WO2010048415A1 Methods of using jak3 genetic variants to diagnose and predict crohn's disease |
| 04/29/2010 | WO2010048388A1 Immunoassays for citrullinated proteins |
| 04/29/2010 | WO2010048354A1 Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal |
| 04/29/2010 | WO2010048347A2 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 04/29/2010 | WO2010048346A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 04/29/2010 | WO2010048330A1 Treatment of cancer using hypoxia activated prodrugs |
| 04/29/2010 | WO2010048304A2 Identification of signature genes associated with hepatocellular carcinoma |
| 04/29/2010 | WO2010048258A1 Reflection-mode photoacoustic tomography using a flexibly-supported cantilever beam |
| 04/29/2010 | WO2010048252A1 Lawsonia intracellularis vaccines |
| 04/29/2010 | WO2010048212A2 Methods and compositions for preventing artifacts in tissue samples |
| 04/29/2010 | WO2010048184A2 Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation) |
| 04/29/2010 | WO2010048173A2 High resolution focusing and separation of proteins in nanofluidic channels |
| 04/29/2010 | WO2010048143A1 Method for predicting hydrocarbon process stream stability using near infrared spectra |
| 04/29/2010 | WO2010048123A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 04/29/2010 | WO2010047829A1 Mutant hepatitis c virus e2 polypeptides for hcv treatment |
| 04/29/2010 | WO2010047827A1 Rapid and safe technique for performing pcr amplifications |
| 04/29/2010 | WO2010047823A2 Detection and modulation of cytochrome c acetylation |
| 04/29/2010 | WO2010047822A2 Methods of using sdf-1 (cxcl12) as a diagnostic and mesenchymal stem cell (multipotent stromal cell)-specific therapeutic biomarker for the treatment of kidney injury and other major organs |
| 04/29/2010 | WO2010047779A2 Integrated bioanalyzer |
| 04/29/2010 | WO2010047778A1 Compositions for the detection of intracellular bacterial targets and other intracellular microorganism targets |
| 04/29/2010 | WO2010047767A2 Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same |
| 04/29/2010 | WO2010047682A1 Monitoring serial changs in circulating breast cancer cells in mice |
| 04/29/2010 | WO2010047419A1 Immobilization substrate and method for producing the same |
| 04/29/2010 | WO2010047310A1 Tumor antigen peptide and use thereof |
| 04/29/2010 | WO2010047191A1 Device for measuring blood cell deformability |
| 04/29/2010 | WO2010047163A1 Method and reagent kit for immunological measurement |
| 04/29/2010 | WO2010047117A1 Novel monoclonal antibody and use thereof |
| 04/29/2010 | WO2010047028A1 Screening method of anti-lung or esophageal cancer compounds |
| 04/29/2010 | WO2010046876A1 Method for the Functional identification of SVZ-derived oligodendrocytes based on selective resuponse to thrombin and utilization thereof |
| 04/29/2010 | WO2010046856A1 A functionalized cyanine having a silane linker arm, a method of preparing thereof and uses thereof |
| 04/29/2010 | WO2010046844A2 Method and device for assessing the structural characteristics of installed supporting poles |
| 04/29/2010 | WO2010046821A1 Colour management for biological samples |
| 04/29/2010 | WO2010046716A1 Neurological autoimmune disorders |
| 04/29/2010 | WO2010046624A1 Assay method for detecting primary amines |
| 04/29/2010 | WO2010046592A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
| 04/29/2010 | WO2010046591A1 Device for controlling lubricant quality and method for controlling the operation of an industrial apparatus using a lubricant |
| 04/29/2010 | WO2010046530A1 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes |
| 04/29/2010 | WO2010046469A1 Test kit for determining odour preferences and odour profiles |
| 04/29/2010 | WO2010046468A1 Method of quality control testing a factor xiii containing sample |
| 04/29/2010 | WO2010046459A1 Methods and device to constrain multicellular arrangements in stable, stationary and reproducible spatial configuration |
| 04/29/2010 | WO2010046443A2 Methods for detection and diagnosis of a bone or cartilage disorder |
| 04/29/2010 | WO2010046411A1 Biomarkers of mineralocorticoid receptor activation |
| 04/29/2010 | WO2010046332A1 Method for detecting soluble amyloid precursor protein (app) alpha and/or soluble app beta |
| 04/29/2010 | WO2010046323A1 Analytical test strip instrument with a direct current motor and gear |
| 04/29/2010 | WO2010046137A1 Prognostic biomarkers for the progression of primary chronic kidney disease |
| 04/29/2010 | WO2010046136A1 Prognosis and risk assessment in stroke patients by determining the level of marker peptides |
| 04/29/2010 | WO2010045949A2 A method and apparatus for analysis of a particle |
| 04/29/2010 | WO2010045931A2 Method and apparatus for monitoring the operating properties of engine oil |
| 04/29/2010 | WO2010045846A1 Method for measuring surface property parameters of a material and system for analyzing surface property parameters of a material based on the method |
| 04/29/2010 | WO2010045714A1 Methods and compositions for the detection of ovarian cancer |
| 04/29/2010 | WO2010045710A1 Methods and reagents for enrichment and characterization of phosphorylated biomolecules |
| 04/29/2010 | WO2010025715A3 Method for precisely determining the fluorescence in a layer system, such as the eye |
| 04/29/2010 | WO2010024704A3 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 04/29/2010 | WO2010024524A3 Nano-scale biochip scanner |
| 04/29/2010 | WO2010022210A3 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 04/29/2010 | WO2010011947A3 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 04/29/2010 | WO2010011931A3 Automated diagnostic workstation |